Systematic Reviews
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Methodol. Jun 20, 2025; 15(2): 98513
Published online Jun 20, 2025. doi: 10.5662/wjm.v15.i2.98513
Strategic insights of telehealth platforms and strengths, weaknesses, opportunities, and threats analysis of Amazon's clinical endeavors
Harpreet Grewal, Gagandeep Dhillon, Venkata Buddhavarapu, Ram Kishun Verma, Ripudaman Singh Munjal, Pranjal Sharma, Gurmanpreet Sidhu, Rahul Kashyap, Salim Surani
Harpreet Grewal, Department of Radiology, Ascension Sacred Heart Hospital, Pensacola, FL 32503, United States
Gagandeep Dhillon, Department of Medicine, UM Baltimore Washington Medical Center, Glen Burnie, MD 21061, United States
Venkata Buddhavarapu, Department of Medicine, Banner Baywood Medical Center, Banner Health, Mesa, AZ 85206, United States
Ram Kishun Verma, Department of Sleep Medicine, Parkview Health System, Fort Wayne, IN 46845, United States
Ripudaman Singh Munjal, Department of Medicine, Touro university College of Osteopathic Medicine, Vallejo, CA 94592, United States
Pranjal Sharma, Department of Nephrology, Northeast Ohio Medical Center, Rootstown, OH 44272, United States
Gurmanpreet Sidhu, Department of Pathology, Government Medical College Patiala, Patiala 147001, Punjab, India
Rahul Kashyap, Department of Research, Wellspan Health, York, PA 17403, United States
Rahul Kashyap, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN 55905, United States
Salim Surani, Department of Medicine & Pharmacology, Texas A&M University, College Station, TX 77843, United States
Author contributions: Grewal H and Kashyap R conceptualized the study and coordinated the research activities; Dhillon G and Budhavarapu V contributed to data analysis, literature review; Verma R, Munjal R, and Sharma P contributed to data collection, methodology section; Sidhu G performed manuscript editing and proofreading; Surani S reviewed and supervised the manuscript.
Conflict-of-interest statement: None of the authors have any conflict of interest to disclose.
PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Salim Surani, FCCP, MD, MS, Professor, Department of Medicine & Pharmacology, Texas A&M University, 40 Bizzell Street, College Station, TX 77843, United States. srsurani@hotmail.com
Received: June 27, 2024
Revised: July 23, 2024
Accepted: July 31, 2024
Published online: June 20, 2025
Processing time: 152 Days and 17.8 Hours
Core Tip

Core Tip: Telemedicine has been in the armamentarium for patient care for a while. It surged during and after the coronavirus disease 2019 pandemic. To address the shortage of healthcare providers and the accessibility of care, business industries and venture capitalists have invested resources in providing 24/7 virtual healthcare. This review discusses telemedicine, its implications, and the role of major organizations such as Amazon in providing telehealth. It also assesses strengths, weaknesses, opportunities, and threats.